Literature DB >> 7698795

Apoptosis and macrophage-mediated cell deletion in the regulation of B lymphopoiesis in mouse bone marrow.

D G Osmond1, S Rico-Vargas, H Valenzona, L Fauteux, L Liu, R Janani, L Lu, K Jacobsen.   

Abstract

Studies of cell population dynamics and microenvironmental organization of B lymphopoiesis in the bone marrow of normal mice and in various genetically modified states have shown that cell loss, involving processes of apoptosis and macrophage-mediated cell deletion, is a prominent feature of the primary genesis of B lymphocytes. Balanced against the influence of proliferative stimulants, the programmed death of precursor B cells provides a quantitative control, determining the magnitude of the final output of functional B lymphocytes to the peripheral immune system. The cell loss mechanisms can be readily set in motion by external or systemic influences, making the B-cell output particularly vulnerable to suppression by ionizing irradiation, stress or other systemic mediators. In addition, however, cell loss exerts an important quality control in the formation of the primary B-cell repertoire. The combination of apoptosis and macrophage-mediated deletion, acting at successive stages of B-cell differentiation, efficiently eliminates many precursors having non-productive Ig gene rearrangements, cell cycle dysregulations, and certain autoreactive Ig specificities. Outstanding areas of further work abound. Important questions concern the nature of mechanisms which underlie the processes of B-cell apoptosis and macrophage deletion in bone marrow, the microenvironmental signals involved in B-cell life or death decisions and genetic factors which may override these B-cell culling mechanisms. The answers will be relevant to problems of autoimmune disease, humoral immunodeficiency and B-cell neoplasia.

Entities:  

Mesh:

Year:  1994        PMID: 7698795     DOI: 10.1111/j.1600-065x.1994.tb00891.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  18 in total

Review 1.  Siglecs in the immune system.

Authors:  P R Crocker; A Varki
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

Review 2.  The role of melatonin in immuno-enhancement: potential application in cancer.

Authors:  Sandra C Miller; S R Pandi-Perumal; Perumal S R Pandi; Ana I Esquifino; Daniel P Cardinali; Georges J M Maestroni
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

3.  Control of B cell development by Ras-mediated activation of Raf.

Authors:  B M Iritani; K A Forbush; M A Farrar; R M Perlmutter
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

4.  Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest.

Authors:  D Melamed; D Nemazee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 5.  How should we sequence and combine novel therapies in CLL?

Authors:  Matthew S Davids
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

6.  Phosphatase Wip1 controls antigen-independent B-cell development in a p53-dependent manner.

Authors:  Weiwei Yi; Xuelian Hu; Zhiyang Chen; Leiming Liu; Yuan Tian; Hui Chen; Yu-Sheng Cong; Fan Yang; Lianfeng Zhang; Karl Lenhard Rudolph; Zhixin Zhang; Yong Zhao; Zhenyu Ju
Journal:  Blood       Date:  2015-05-26       Impact factor: 22.113

7.  Variance in the resistance of murine early bone marrow B cells to a deficiency in zinc.

Authors:  F Osati-Ashtiani; L E King; P J Fraker
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

8.  BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3.

Authors:  Joji Nakayama; Mutsumi Yamamoto; Katsuhiko Hayashi; Hitoshi Satoh; Kenji Bundo; Masato Kubo; Ryo Goitsuka; Michael A Farrar; Daisuke Kitamura
Journal:  Blood       Date:  2008-12-01       Impact factor: 22.113

9.  Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance.

Authors:  Antonina V Kurtova; Kumudha Balakrishnan; Rong Chen; Wei Ding; Susanne Schnabl; Maite P Quiroga; Mariela Sivina; William G Wierda; Zeev Estrov; Michael J Keating; Medhat Shehata; Ulrich Jäger; Varsha Gandhi; Neil E Kay; William Plunkett; Jan A Burger
Journal:  Blood       Date:  2009-09-17       Impact factor: 22.113

Review 10.  Neutrophil mobilization and clearance in the bone marrow.

Authors:  Rebecca C Furze; Sara M Rankin
Journal:  Immunology       Date:  2008-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.